A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit–positive Acute Myeloid Leukemia
Advani, Anjali S., Tse, William, Li, Hong, Jia, Xuefei, Elson, Paul, Cooper, Brenda, Ali-Osman, Francis, Park, Jino, Rao, Arati V., Rizzieri, David A., Wang, Eunice S., Cotta, Claudiu V., Kalaycio, Matt, Sobecks, Ronald M., Rouphail, Basel, Maciejewski, Jaroslaw P., Fensterl, Jaime, Carew, Jennifer S., Foster, Bethany, Rush, Mary Lynn, Tripp, Barbara, Adams, Donna, Corrigan, Donna, Griffiths, Elizabeth A., Sekeres, Mikkael A.
Published in Clinical lymphoma, myeloma and leukemia (01.02.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.02.2021)
Get full text
Journal Article
A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML): Final Results
Advani, Anjali S., Cooper, Brenda W., Visconte, Valeria, Elson, Paul, Chan, E. Ricky, Carew, Jennifer, Mukherjee, Sudipto, Gerds, Aaron T., Carraway, Hetty E., Nazha, Aziz, Hamilton, Betty K., Sobecks, Ronald, Caimi, Paolo, Tomlinson, Benjamin, Malek, Ehsan, Little, Jane A., Fensterl, Jaime, Unger, Allison, Zimmerman, Cassie, Goebel, Christopher, Hoxha, Nita, Siebenaller, Caitlin, Thomas, Jenna, Rush, Mary Lynn, Bogati, Samjhana, Parsons, Eric, Diligente, Rachael, Kane, Donna, Nielsen, Alek, Hirsch, Cassandra M., Edelheit, Simone, Miron, Alexander, Pink, John, Maciejewski, Jaroslaw P., Kalaycio, Matt, De Lima, Marcos, Sekeres, Mikkael A.
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib (MLN9708) for Relapsed/ Refractory Acute Myeloid Leukemia (AML)
Advani, Anjali S., Cooper, Brenda, Elson, Paul, Mukherjee, Sudipto, Fensterl, Jaime, Gerds, Aaron T., Caimi, Paolo F., Tomlinson, Ben K., Malek, Ehsan, Little, Jane A., Rush, Mary Lynn, Bogati, Samjhana, Parsons, Eric, Kane, Donna, Carraway, Hetty E., Nazha, Aziz, Hamilton, Betty K., Sobecks, Ronald, Bevier, Barbara, Goebel, Christopher, Zimmerman, Cassie, Nielsen, Alek d, Hirsch, Cassandra M., Maciejewski, Jaroslaw P., Kalaycio, Matt, deLima, Marcos, Jacobberger, James, Woost, Philip, Sekeres, Mikkael A.
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Long-Term Follow-up Results: A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed c-Kit Positive Acute Myeloid Leukemia (AML)
Advani, Anjali S., Tse, William, Jia, Xuefei, Elson, Paul, Cooper, Brenda, Ali-Osman, Francis, Park, Jino, Rao, Arati V., Rizzieri, David A., Wang, Eunice S., Cotta, Claudiu V., Kalaycio, Matt, Sobecks, Ronald M., Rouphail, Basel, Maciejewski, Jaroslaw P., Fensterl, Jaime, Bailey, Laura, Carew, Jennifer S., Foster, Bethany, Rush, Mary Lynn, Adams, Donna, Griffiths, Elizabeth A., Sekeres, Mikkael A.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
A Phase 1 Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Bortezomib for Relapsed/Refractory Acute Myeloid Leukemia
Advani, Anjali, Elson, Paul, Hsi, Eric D., Davis, Randall, Kalaycio, Matt, Sobecks, Ronald, Copelan, Edward, Duong, Hien K., Foster, Bethany, Rush, Mary Lynn, Farhat, Leslie, Sekeres, Mikkael A.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Bortezomib + MEC (Mitoxantrone, Etoposide, Cytarabine) for Relapsed/ Refractory Acute Myeloid Leukemia: Final Results of an Expanded Phase 1 Trial
Advani, Anjali S., Elson, Paul, Kalaycio, Matt E., Mukherjee, Sudipto, Gerds, Aaron T., Hamilton, Betty K., Hobson, Sean, Smith, Arian, Rush, Mary Lynn, Bogati, Samjhana, Biggins, Monique, Hsi, Eric D., Duong, Hien K., Copelan, Edward A., Reu, Frederic J., Saunthararajah, Yogen, Nazha, Aziz, Makishima, Hideki, Przychodzen, Bartlomiej, Dienes, Brittney, Maciejewski, Jaroslaw P., Carew, Jennifer S, Carraway, Hetty E., Sekeres, Mikkael A.
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed C-Kit Positive Acute Myeloid Leukemia (AML)
Advani, Anjali, Cooper, Brenda, Sowunmi, Olumuyiwa, Elson, Paul, Ali-Osman, Francis, Park, Jino, Rao, Arati, Rizzieri, David A., Wang, Eunice S., Cotta, Claudiu, Sekeres, Mikkael A., Kalaycio, Matt, Sobecks, Ronald, Rouphail, Basel, Maciejewski, Jaroslaw P., Davis, Randall, Bailey, Laura, Foster, Bethany, Rush, Mary Lynn, Adams, Donna, Tse, William
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia
Advani, Anjali S, Tiu, Ramon, Saunthararajah, Yogen, Maciejewski, Jaroslaw, Copelan, Edward A, Sobecks, Ronald, Sekeres, Mikkael A, Bates, Jennifer, Rush, Mary Lynn, Tripp, Barbara, Salvado, August, Noon, Elysa, Howard, Matthew, Jin, Tao, Hsi, Eric, Egorin, Merrill J, Lim, Kathleen, Cotta, Claudiu V, Price, Courtney, Kalaycio, Matt
Published in Leukemia research (01.12.2010)
Published in Leukemia research (01.12.2010)
Get full text
Journal Article
A Phase 1 Trial of Imatinib Mesylate with Daunorubicin and Cytarabine for Patients with C-Kit Positive Relapsed AML
Advani, Anjali, Copelan, Edward A., Sobecks, Ronald, Sekeres, Mikkael A, Bates, Jennifer, Rush, Mary Lynn, Tripp, Barbara, Noon, Elysa, Howard, Matthew, Jin, Tao, Hsi, Eric, Kalaycio, Matt
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article